Dyne Therapeutics (DYN) Shares Outstanding (2019 - 2026)

Dyne Therapeutics' Shares Outstanding history runs 8 years deep, the most recent figure standing at $165.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 45.38% year-over-year to $165.2 million; the TTM figure through Mar 2026 stood at $165.2 million (up 45.38% YoY), while the FY2025 annual figure was $165.0 million, up 61.21% from the prior year.
• Shares Outstanding was $165.2 million for Q1 2026 at Dyne Therapeutics, roughly flat from $165.0 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $165.2 million in Q1 2026 to a low of $51.6 million in Q1 2022.
• Historically, Shares Outstanding has averaged $90.9 million across 5 years, with a median of $87.1 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding rose 0.82% in 2022, then soared 66.46% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $55.6 million in 2022, then increased by 10.48% to $61.5 million in 2023, then jumped by 66.46% to $102.3 million in 2024, then soared by 61.21% to $165.0 million in 2025, then rose by 0.15% to $165.2 million in 2026.
• The last three Shares Outstanding figures came in at $165.2 million (Q1 2026), $165.0 million (Q4 2025), and $142.6 million (Q3 2025), per Business Quant data.